Westfield Capital Management
AGN

Westfield Capital Management’s Allergan Inc AGN Stock Holding History

Westfield Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,860
Closed -$982K – 389
2013
Q3 		$982K Buy
+10,860
New +$975K 0.01% 287

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Westfield Capital Management's AGN Position: Q4 2013 in Review

Westfield Capital Management sold out of Allergan Inc (AGN) in Q4 2013, closing a stake of 10,860 shares — an estimated $982K sold.

Westfield Capital Management first reported a position in AGN in Q3 2013 and held it in 1 quarter. The position peaked at $982K in Q3 2013. 709 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

  • Westfield Capital Management reported no remaining Allergan Inc position as of Q4 2013 after selling out during the quarter.
  • Westfield Capital Management sold 10,860 Allergan Inc shares in Q4 2013, an estimated $982K.
  • Westfield Capital Management first reported a position in Allergan Inc in Q3 2013 and held it in 1 quarter.
  • Westfield Capital Management's Allergan Inc position peaked at $982K in Q3 2013.
  • 709 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2013.

Based on Westfield Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.